Cited by 26Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

STING Deletion Protects Against Amyloid β‐induced Alzheimer's Disease Pathogenesis

Open access
Thanos, Jessica M., Campbell, Olivia C., Cowan, Maureen N., Bruch, Katherine R., Moore, Katelyn A., Ennerfelt, Hannah E., Natale, Nick R., Mangalmurti, Aman +2 more·2025·Alzheimer's & Dementia

Abstract

INTRODUCTION: While immune dysfunction has been increasingly linked to Alzheimer's disease (AD) progression, many major innate immune signaling molecules have yet to be explored in AD pathogenesis using genetic targeting approaches. METHODS: To investigate a role for the key innate immune adaptor molecule, stimulator of interferon genes (STING), in AD, we deleted Sting1 in the 5xFAD mouse model of AD‐related amyloidosis and evaluated the effects on pathology, neuroinflammation, gene expression, and cognition. RESULTS: Genetic ablation of STING in 5xFAD mice led to improved control of amyloid beta (Aβ) plaques, alterations in microglial activation status, decreased levels of neuritic dystrophy, and protection against cognitive decline. Moreover, rescue of neurological disease in STING‐deficient 5xFAD mice was characterized by reduced expression of type I interferon signaling genes in both microglia and excitatory neurons. DISCUSSION: These findings reveal critical roles for STING in Aβ‐driven neurological disease and suggest that STING‐targeting therapeutics may offer promising strategies to treat AD. Highlights: Stimulator of interferon genes (STING) deficiency in the 5xFAD mouse model of Alzheimer's disease‐related amyloidosis results in decreased amyloid beta (Aβ) deposition and altered microglial activation status. Protection against amyloidosis in STING‐deficient 5xFAD mice is associated with decreased expression of genes involved in type I IFN signaling, improved neuronal health, and reduced levels of oxidative stress. Loss of STING in 5xFAD mice leads to improved spatial learning and memory.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.70305

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • STING interacts with cGAS and plays a significant role in Alzheimer's disease by promoting microglial dysfunction and neuroinflammation.

    “The STING interacts with cGAS and plays a significant role in Alzheimer's disease by promoting microglial dysfunction and neuroinflammation [66, 67].”

    From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [67]

    The Background describes cGAS as an upstream activator of STING, and the Results report that STING deletion dampened microglial activation and innate immune signaling in 5xFAD mice. But the Discussion says the cell types through which cGAS and STING promote AD-related progression remain undetermined, so the claim that STING acts *by* promoting microglial dysfunction states a mechanism more firmly than this paper establishes. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. [1]Heneka MT, van der Flier WM, Jessen F, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025; 25: 321‐ 352. 39653749 PMC13148177
  2. [3]Ennerfelt HE, Lukens JR. The role of innate immunity in Alzheimer's disease. Immunol Rev. 2020; 297: 225‐ 246. 32588460 PMC7783860
  3. [4]Johnson AM, Lukens JR. The innate immune response in tauopathies. Eur J Immunol. 2023; 53: e2250266. 36932726 PMC10247424
  4. [5]Samuels JD, Lukens JR, Price RJ. Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease‐related amyloidosis. J Neurochem. 2024; 168: 3558‐ 3573. 37822118 PMC11955997
  5. [6]Efthymiou AG, Goate AM. Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017; 12: 43. 28549481 PMC5446752
  6. [8]Karch CM, Goate AM. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015; 77: 43‐ 51. 24951455 PMC4234692
  7. [9]Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS‐STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021; 21: 548‐ 569. 33833439 PMC8029610
  8. [10]Yang K, Tang Z, Xing C, Yan N. STING signaling in the brain: molecular threats, signaling activities, and therapeutic challenges. Neuron. 2024; 112: 539‐ 557. 37944521 PMC10922189
  9. [11]Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019; 363:eaat8657. 30846571
  10. [12]Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008; 455: 674‐ 678. 18724357 PMC2804933
  11. [13]Ablasser A, Goldeck M, Cavlar T, et al. cGAS produces a 2'‐5'‐linked cyclic dinucleotide second messenger that activates STING. Nature. 2013; 498: 380‐ 384. 23722158 PMC4143541
  12. [14]Civril F, Deimling T, de Oliveira Mann CC, et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 2013; 498: 332‐ 337. 23722159 PMC3768140
  13. [15]Burdette DL, Monroe KM, Sotelo‐Troha K, et al. STING is a direct innate immune sensor of cyclic di‐GMP. Nature. 2011; 478: 515‐ 518. 21947006 PMC3203314
  14. [16]Yu CH, Davidson S, Harapas CR, et al. TDP‐43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell. 2020; 183: 636‐ 649. 33031745 PMC7599077
  15. [18]Hinkle JT, Patel J, Panicker N, et al. STING mediates neurodegeneration and neuroinflammation in nigrostriatal alpha‐synucleinopathy. Proc Natl Acad Sci U S A. 2022; 119: e2118819119. 35394877 PMC9169780
  16. [20]Huang Y, Liu B, Sinha SC, Amin S, Gan L. Mechanism and therapeutic potential of targeting cGAS‐STING signaling in neurological disorders. Mol Neurodegener. 2023; 18: 79. 37941028 PMC10634099
  17. [23]Barasa L, Chaudhuri S, Zhou JY, et al. Development of LB244, an irreversible STING antagonist. J Am Chem Soc. 2023; 145: 20273‐ 20288. 37695732 PMC11059204
  18. [24]Hong Z, Mei J, Li C, et al. STING inhibitors target the cyclic dinucleotide binding pocket. Proc Natl Acad Sci U S A. 2021; 118: e2105465118. 34099558 PMC8214703
  19. [26]Jin L, Hill KK, Filak H. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic‐di‐AMP and cyclic‐di‐GMP. J Immunol. 2011; 187: 2595‐ 2601. 21813776 PMC3159690
  20. [27]Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018; 560: 185‐ 191. 30046111 PMC6085146
  21. [28]Wolf FA, Angerer P, Theis FJ. SCANPY: large‐scale single‐cell gene expression data analysis. Genome Biol. 2018; 19: 15. 29409532 PMC5802054
  22. [30]Bernstein NJ, Fong NL, Lam I, Roy MA, Hendrickson DG, Kelley DR. Solo: doublet identification in single‐cell RNA‐Seq via semi‐supervised deep learning. Cell Syst. 2020; 11: 95‐ 101. 32592658
  23. [32]Eraslan G, Drokhlyansky E, Anand S, et al. Single‐nucleus cross‐tissue molecular reference maps toward understanding disease gene function. Science. 2022; 376: eabl4290. 35549429 PMC9383269
  24. [34]Ferecsko AS, Smallwood MJ, Moore A, et al. STING‐triggered CNS inflammation in human neurodegenerative diseases. Biomedicines. 2023; 11. PMC10216406 37239045
  25. [35]Suberbielle E, Sanchez PE, Kravitz AV, et al. Physiologic brain activity causes DNA double‐strand breaks in neurons, with exacerbation by amyloid‐beta. Nat Neurosci. 2013; 16: 613‐ 621. 23525040 PMC3637871
  26. [36]Shanbhag NM, Evans MD, Mao W, et al. Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease. Acta Neuropathol Commun. 2019; 7: 77. 31101070 PMC6524256
  27. [37]Ren J, Zhang S, Wang X, et al. MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer's disease in vivo and in vitro. Acta Biochim Biophys Sin. 2022; 54: 77‐ 90. 35130621 PMC9909301
  28. [39]Woo RS, Lee JH, Yu HN, Song DY, Baik TK. Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease. Anat Cell Biol. 2011; 44: 116‐ 127. 21829755 PMC3145840
  29. [40]Lee HJ, Jung KM, Huang YZ, et al. Presenilin‐dependent gamma‐secretase‐like intramembrane cleavage of ErbB4. J Biol Chem. 2002; 277: 6318‐ 6323. 11741961
  30. [41]Zhang H, Zhang L, Zhou D, et al. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease. Neurobiol Dis. 2017; 106: 171‐ 180. 28684271
  31. [42]Zhang H, Zhang L, Zhou D, Li H, Xu Y. ErbB4 mediates amyloid beta‐induced neurotoxicity through JNK/tau pathway activation: implications for Alzheimer's disease. J Comp Neurol. 2021; 529: 3497‐ 3512. 34212389
  32. [43]Montine TJ, Neely MD, Quinn JF, et al. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med. 2002; 33: 620‐ 626. 12208348
  33. [44]Garcia‐Alloza M, Dodwell SA, Meyer‐Luehmann M, Hyman BT, Bacskai BJ. Plaque‐derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol. 2006; 65: 1082‐ 1089. 17086105
  34. [45]Ferre‐Gonzalez L, Pena‐Bautista C, Baquero M, Chafer‐Pericas C. Assessment of lipid peroxidation in Alzheimer's disease differential diagnosis and prognosis. Antioxidants (Basel). 2022; 11: 551. 35326200 PMC8944831
  35. [46]Lopez N, Tormo C, De Blas I, Llinares I, Alom J. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis. 2013; 33: 823‐ 829. 23076075
  36. [47]Zhao Y, Wu X, Li X, et al. TREM2 is a receptor for beta‐amyloid that mediates microglial function. Neuron. 2018; 97: 1023‐ 1031. 29518356 PMC5889092
  37. [48]Jay TR, Hirsch AM, Broihier ML, et al. Disease progression‐dependent effects of TREM2 deficiency in a mouse model of Alzheimer's disease. J Neurosci. 2017; 37: 637‐ 647. 28100745 PMC5242410
  38. [51]Wang Y, Cella M, Mallinson K, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015; 160: 1061‐ 1071. 25728668 PMC4477963
  39. [53]Yuan P, Condello C, Keene CD, et al. TREM2 Haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016; 92: 252‐ 264. 27710785
  40. [54]Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, Colonna M. Humanized TREM2 mice reveal microglia‐intrinsic and ‐extrinsic effects of R47H polymorphism. J Exp Med. 2018; 215: 745‐ 760. 29321225 PMC5839761
  41. [55]Leyns CEG, Gratuze M, Narasimhan S, et al. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci. 2019; 22: 1217‐ 1222. 31235932 PMC6660358
  42. [58]Carling GK, Fan L, Foxe NR, et al. Alzheimer's disease‐linked risk alleles elevate microglial cGAS‐associated senescence and neurodegeneration in a tauopathy model. Neuron. 2024; 112: 3877‐ 3896. 39353433 PMC11624100
  43. [59]Jeltema D, Abbott K, Yan N. STING trafficking as a new dimension of immune signaling. J Exp Med. 2023; 220: e20220990. 36705629 PMC9930166
  44. [60]Szabo MP, Mishra S, Knupp A, Young JE. The role of Alzheimer's disease risk genes in endolysosomal pathways. Neurobiol Dis. 2022; 162: 105576. 34871734 PMC9071255
  45. [61]Liu Y, Wang A, Chen C, et al. Microglial cGAS‐STING signaling underlies glaucoma pathogenesis. Proc Natl Acad Sci U S A. 2024; 121: e2409493121. 39190350 PMC11388346
  46. [62]Marques C, Held A, Dorfman K, et al. Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol. 2024; 147: 56. 38478117 PMC10937762
  47. [63]Woo MS, Mayer C, Binkle‐Ladisch L, et al. STING orchestrates the neuronal inflammatory stress response in multiple sclerosis. Cell. 2024; 187: 4043‐ 4060. 38878778
  48. [64]Gate D, Saligrama N, Leventhal O, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020; 577: 399‐ 404. 31915375 PMC7445078
  49. [66]Machhi J, Yeapuri P, Lu Y, et al. CD4+ effector T cells accelerate Alzheimer's disease in mice. J Neuroinflammation. 2021; 18: 272. 34798897 PMC8603581
  50. [67]Chen X, Firulyova M, Manis M, et al. Microglia‐mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023; 615: 668‐ 677. 36890231 PMC10258627
  51. [68]Su W, Saravia J, Risch I, et al. CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer's disease pathology. Nat Immunol. 2023; 24: 1735‐ 1747. 37679549 PMC11102766
  52. [69]Larkin B, Ilyukha V, Sorokin M, Buzdin A, Vannier E, Poltorak A. Cutting edge: activation of STING in T cells induces type I IFN responses and cell death. J Immunol. 2017; 199: 397‐ 402. 28615418 PMC5525333
  53. [71]Wu J, Chen YJ, Dobbs N, et al. STING‐mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death. J Exp Med. 2019; 216: 867‐ 883. 30886058 PMC6446864
  54. [72]Pais TF, Ali H, Moreira da Silva J, et al. Brain endothelial STING1 activation by Plasmodium‐sequestered heme promotes cerebral malaria via type I IFN response. Proc Natl Acad Sci U S A. 2022; 119: e2206327119. 36037380 PMC9457060
  55. [73]Liu H, Ghosh S, Vaidya T, et al. Activated cGAS/STING signaling elicits endothelial cell senescence in early diabetic retinopathy. JCI Insight. 2023; 8: e168945. 37345657 PMC10371250
  56. [74]Gao KM, Chiang K, Jiang Z, et al. Endothelial cell expression of a STING gain‐of‐function mutation initiates pulmonary lymphocytic infiltration. Cell Rep. 2024; 43: 114114. 38625791 PMC11108094
  57. [75]Wang A, Chen C, Mei C, et al. Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nat Cell Biol. 2024; 26: 219‐ 234. 38253667

Cited by

Sorted by citations

Authors
Thanos, J. M., Campbell, O. C., Cowan, M. N., Bruch, K. R., Moore, K. A., Ennerfelt, H. E., Natale, N. R., Mangalmurti, A., Kerur, N., & Lukens, J. R.
Affiliations
  • University of Virginia (US)
  • Massachusetts General Hospital (US)
  • Stanford University (US)
  • The Ohio State University Wexner Medical Center (US)
Corresponding author
Lukens, John R.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2025-05
Volume
21
Issue
5
Pages
e70305-e70305
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4410638645
Cited by
26
References
18
Citations by year
2026: 17 · 2025: 9
FWCI
16.73
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (R01AG071996, R01AG087406, RF1AG078684)
  • National Institute of Neurological Disorders and Stroke (T32NS115657)
  • Owens Family Foundation (Grant)
  • Cure Alzheimer's Fund (Grant)
  • Alzheimer's Association (ADSF‐21‐816651)
  • National Institute on Aging (RF1AG078684)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
STING, Alzheimer's disease
MeSH terms
STING Protein, Alzheimer Disease, Animals, Disease Models, Animal, Humans, Membrane Proteins, Mice, Transgenic, Amyloid beta-Peptides, Microglia, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review